Literature DB >> 7787593

Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

J Adami1, M Frisch, J Yuen, B Glimelius, M Melbye.   

Abstract

OBJECTIVE: To investigate a possible link between exposure to ultraviolet light and the almost epidemic increase in non-Hodgkin's lymphoma worldwide. Because ultraviolet light is known to cause skin cancers, the association between non-Hodgkin's lymphoma and skin cancer was studied.
DESIGN: Secondary occurrence of either malignant melanoma or squamous cell skin cancer in cohorts of patients with a first diagnosis of either non-Hodgkin's lymphoma or chronic lymphocytic leukaemia, and vice versa, were studied. Expected numbers of subsequent cancers were calculated by sex, age, and period specific national incidence rates multiplied by the person years under observation in the cohorts.
SETTING: Denmark (1943-89) and Sweden (1958-89).
SUBJECTS: Four population based cohorts identified in the nationwide cancer registries (34,641 people with non-Hodgkin's lymphoma, 17,400 with chronic lymphocytic leukaemia, 34,989 with malignant melanoma, 25,980 with squamous cell skin cancer). A total of 562,085 person years were accrued for the analysis. MAIN OUTCOME MEASURES: The ratios of observed to expected cancers (the standardised incidence ratio) served as a measure of the relative risk.
RESULTS: The relative risk for developing squamous cell skin cancer was 5.5 (95% confidence interval 4.6 to 6.6) among patients with non-Hodgkin's lymphoma and 8.6 (7.2 to 10.3) among patients with chronic lymphocytic leukaemia. The relative risks remained high over more than 15 years of follow up. Relative risks for malignant melanoma were 2.4 (1.8 to 3.2) for patients with non-Hodgkin's lymphoma and 3.1 (2.1 to 4.4) for patients with chronic lymphocytic leukaemia. After squamous cell skin cancer had been diagnosed there was a twofold excess risk for non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. By contrast, in each of the cohorts the general cancer risks excluding skin and lymphoproliferative malignancies were close to the expected.
CONCLUSIONS: The occurrence of non-Hodgkin's lymphoma and skin cancer are strongly associated; this supports the hypothesis that the secular increase in exposure to ultraviolet light may have contributed to the increasing incidence of non-Hodgkin's lymphoma in recent decades.

Entities:  

Mesh:

Year:  1995        PMID: 7787593      PMCID: PMC2549874          DOI: 10.1136/bmj.310.6993.1491

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Chemotherapy for large-cell lymphoma: optimism and caution.

Authors:  M Coleman
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

2.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

Review 3.  Immunologic mechanisms in UV radiation carcinogenesis.

Authors:  M L Kripke
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

4.  Cancer morbidity in blood recipients--results of a cohort study.

Authors:  J Blomberg; T Möller; H Olsson; H Anderson; M Jonsson
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland.

Authors:  T Hakulinen; H Isomaki; P Knekt
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

6.  Immunological effects of solarium exposure.

Authors:  P Hersey; M Bradley; E Hasic; G Haran; A Edwards; W H McCarthy
Journal:  Lancet       Date:  1983-03-12       Impact factor: 79.321

7.  Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight.

Authors:  P Hersey; G Haran; E Hasic; A Edwards
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  Malignancies that occur before and after anal cancer: clues to their etiology.

Authors:  M Frisch; J H Olsen; M Melbye
Journal:  Am J Epidemiol       Date:  1994-07-01       Impact factor: 4.897

9.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

Authors:  L J Kinlen; A G Sheil; J Peto; R Doll
Journal:  Br Med J       Date:  1979-12-08

10.  Enhanced lymphoma incidence in BALB/c mice after ultraviolet light treatment.

Authors:  P Ebbesen
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

View more
  62 in total

1.  Are we really dying for a tan?

Authors:  A R Ness; S J Frankel; D J Gunnell; G D Smith
Journal:  BMJ       Date:  1999-07-10

Review 2.  Bilateral hand squamous-cells carcinoma in patient affected with non-Hodgkin lymphoma. Case report and literature review.

Authors:  P Fino; A M Spagnoli; M Ruggieri; M Marcasciano; N Scuderi
Journal:  G Chir       Date:  2015 Jul-Aug

3.  Exposure to non-arsenic pesticides is associated with lymphoma among farmers in Spain.

Authors:  E van Balen; R Font; N Cavallé; L Font; M Garcia-Villanueva; Y Benavente; P Brennan; S de Sanjose
Journal:  Occup Environ Med       Date:  2006-06-06       Impact factor: 4.402

Review 4.  Vitamin D and non-Hodgkin lymphoma risk in adults: a review.

Authors:  Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher
Journal:  Cancer Invest       Date:  2009-11       Impact factor: 2.176

5.  Non-Hodgkin's lymphoma and skin cancer. Association may be iatrogenic.

Authors:  M Vickers
Journal:  BMJ       Date:  1995-09-16

6.  Non-Hodgkin's lymphoma and skin cancer. American data refute ultraviolet hypothesis.

Authors:  R Newton
Journal:  BMJ       Date:  1995-09-16

7.  Non-Hodgkin's lymphoma and skin cancer. Ultraviolet light is unlikely explanation for association.

Authors:  P Sasieni; V Bataille
Journal:  BMJ       Date:  1995-09-16

8.  Non-Hodgkin's lymphoma and skin cancer. Pathogenesis is multifactorial.

Authors:  R Gniadecki
Journal:  BMJ       Date:  1995-09-16

Review 9.  Melanoma in immunosuppressed patients.

Authors:  Agnieszka W Kubica; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

10.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.